Change of opinion on the use of hydroxychloroquine for COVID-19 treatment and prevention
Open Access
- 28 October 2020
- journal article
- Published by Publishing House OKI in Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice
- No. 4S,p. 90-91
- https://doi.org/10.37489/2588-0519-2020-s4-90-91
Abstract
The use of hydroxychloroquine for COVID-19 treatment and prevention should be restricted in both out- and inpatient settings due to the lack of evidence for effectiveness and unfavorable safety profile.Keywords
This publication has 3 references indexed in Scilit:
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19The New England Journal of Medicine, 2020
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trialInternational Journal of Antimicrobial Agents, 2020
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Clinical Infectious Diseases, 2020